Cambridge researchers have shown that removing the ovaries and fallopian tubes of women with breast cancer who carry certain ...

Researchers conducted a retrospective multicenter cohort study analyzing 575 female patients with BRCA1 or BRCA2 pathogenic ...

For carriers of pathogenic variants in BRCA1 and BRCA2 with a personal history of breast cancer, bilateral ...

Jeff Pomeranz was city manager in West Des Moines when the community was approached around 2008 by a consultant looking for land on which to build a data center for Microsoft Corp. At the time, ...

Women diagnosed with breast cancer who carry particular BRCA1 and BRCA2 genetic variants are offered surgery to remove the ovaries and fallopian tubes as this dramatically reduces their risk of ...

Women diagnosed with breast cancer who carry particular BRCA1 and BRCA2 genetic variants are offered surgery to remove the ovaries and fallopian tubes as this dramatically reduces their risk of ...

Women diagnosed with breast cancer who carry particular BRCA1 and BRCA2 genetic variants are offered surgery to remove the ...

Application error: a client-side exception has occurred (see the browser console for more information).

Mohammad Mahmoud, MD, MS, reviews important updates in metastatic prostate cancer presented at AUA 2025, including promising ...

Lantern Pharma's LP-184 advances to Phase 1b/2 trial in TNBC after FDA clearance, adding to its Fast Track and Rare Pediatric Disease designations.